Apical surgery in cancer patients receiving high-dose antiresorptive medication-a retrospective clinical study with a mean follow-up of 13 months.
Sanne Werner Moeller AndersenSimon Storgaard JensenMorten SchiodtPublished in: Oral and maxillofacial surgery (2020)
The present case series suggest that apical surgery is a valid treatment option for apical periodontitis in patients on HDAR, where orthograde endodontic retreatment is not possible. None of the patients developed medication-related osteonecrosis of the jaw. Further studies in larger study groups and with longer follow-up periods are needed. The regional scientific ethical committee provided a document exemption, registration date 20 November 2013, and the local data protection agency approved handling of the recorded data (No. 2012-41-0045), registration date 11 January 2012.
Keyphrases
- end stage renal disease
- high dose
- newly diagnosed
- minimally invasive
- ejection fraction
- chronic kidney disease
- healthcare
- prognostic factors
- low dose
- emergency department
- coronary artery bypass
- clinical trial
- electronic health record
- machine learning
- stem cell transplantation
- adverse drug
- atrial fibrillation
- lymph node metastasis